AstraZeneca antibody cocktail works against Omicron in study

AstraZeneca antibody cocktail works against Omicron in study
AstraZeneca antibody cocktail works against Omicron in study Copyright Thomson Reuters 2021
By Reuters
Share this articleComments
Share this articleClose Button

- AstraZeneca said on Thursday a lab-study of its COVID-19 antibody cocktail, Evusheld, found that the treatment retained neutralising activity against the Omicron coronavirus variant, showing promise for wider use of the therapy.

The study was conducted by independent investigators of the U.S. Food and Drug Administration, the company said, adding that more analyses of Evusheld against Omicron are being conducted by AstraZeneca and third-parties, with data expected "very soon".

Share this articleComments

You might also like

Golf legends compete in Hassan II Golf Trophy tournament in Morocco

Netanyahu presents first plan for post-war Gaza

Judge convicts former Austrian Chancellor Sebastian Kurz